Sorted By:

Relevance


340B

PhRMA  |  From PhRMA

click here for even more information on 340B.
https://www.phrma.org/advocacy/340b

340B Then & Now

PhRMA  |  Graphic

A closer look at how the 340B program has evolved since its creation in 1992.
https://www.phrma.org/graphic/340b-then-and-now

New analysis finds 340B medicine sales hit record high in 2017 and continue to grow as a share of total drug spending

PhRMA  |  Blog Post

Read the full white paper here and learn more about 340B at PhRMA.org/340B.
https://catalyst.phrma.org/new-analysis-finds-340b-medicine-sales-hit-record-high-in-2017-and-continue-to-grow-as-a-share-of-total-drug-spending

New study finds hospitals prescribe more medicines, and more expensive medicines, after joining 340B program

PhRMA  |  Blog Post

To learn more about the 340B program and ways it could be fixed, visit PhRMA.org/340B.
https://catalyst.phrma.org/new-study-finds-hospitals-prescribe-more-medicines-and-more-expensive-medicines-after-joining-340b-program-to-capitalize-on-significant-discounts

340B continues to drive shift in site of care for physician-administered medicines to more expensive hospital settings

PhRMA  |  Blog Post

To learn more about the 340B program and ways it could be fixed, visit PhRMA.org/340B.
https://catalyst.phrma.org/340b-continues-to-drive-shift-in-site-of-care-for-physician-administered-medicines-to-more-expensive-hospital-settings

Nearly 1 in 5 Hospitals Marks Up Medicine Prices at Least 700 Percent

PhRMA  |  Press Release

Of note, average markups are likely much higher at hospitals that participate in the 340B drug pricing program because medicines acquired by 340B hospitals are purchased, on average, at a 50 percent discount.
https://www.phrma.org/nearly-1-in-5-hospitals-marks-up-medicine-prices-at-least-700-percent

Director – 340B & Payment Policy

PhRMA  |  PhRMA Career

www.Innovation.orgwww.GoBoldly.com www.Facebook.com/PhRMA www.Twitter.com/PhRMA What we offerIn addition to a highly competitive salary, generous 401(k) employer contribution and a platform of extensive benefits, PhRMA is committed to the development and overall wellbeing of our team members. 
https://www.phrma.org/careers/director-340b-and-payment-policy

340B Spotlight: Myth vs. Fact

PhRMA  |  Graphic

Congress created the 340B program in 1992 to help health care safety-net facilities that serve a large proportion of needy or uninsured patients have access to discounted prescription medicines.
https://www.phrma.org/graphic/340b-spotlight-myth-vs-fact

Fresh data show, yet again, 340B is growing while charity care dwindles at many 340B hospitals

PhRMA  |  Blog Post

We also watch as charity care rates at many 340B hospitals decrease.
https://catalyst.phrma.org/fresh-data-show-yet-again-340b-is-growing-while-charity-care-dwindles-at-many-340b-hospitals

340B Spotlight: A look at 340B eligibility and charity care

PhRMA  |  Blog Post

Stricter 340B eligibility criteria are needed to address the market distorting effects of the 340B program.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-spotlight-a-look-at-340b-eligibility-and-charity-care

340B Spotlight: A lack of charity care among 340B hospitals

PhRMA  |  Blog Post

For more check out our chart pack or stay up-to-date on the latest 340B news with our 340B Spotlight posts.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-spotlight-a-lack-of-charity-care-among-340b-hospitals

ICYMI: Has the 340B Program Lost Its Way?

PhRMA  |  Blog Post

To learn more about 340B follow our 340B Spotlight blog posts or sign-up for personalized email updates.
https://catalyst.phrma.orghttp://catalyst.phrma.org/icymi-has-the-340b-program-lost-its-way

340B Mega Guidance

PhRMA  |  Blog Post

Subscribe to industry alerts for issues such as 340B, access to medicines & more.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-mega-guidance

PhRMA Statement on 340B PAUSE Act

PhRMA  |  Press Release

“This legislation provides Congress with a much-needed opportunity to closely evaluate 340B and ways it can be fixed to the benefit of patients.”
https://www.phrma.org/press-release/phrma-statement-on-340b-pause-act

340B Spotlight: 340B hospitals continue to benefit from consolidation at expense of patients

PhRMA  |  Blog Post

This markup becomes even more egregious, 79 percent, if the hospital was able to acquire the drug at the 340B discounted price.
https://catalyst.phrma.org/340b-spotlight-340b-hospitals-continue-to-benefit-from-consolidation-at-expense-of-patients

340B Spotlight: Audit findings show importance of increased oversight of 340B program

PhRMA  |  Blog Post

Learn more about the 340B program at PhRMA.org/340B.
https://catalyst.phrma.org/340b-spotlight-audit-findings-show-importance-of-increased-oversight-of-340b-program

340B: Keeping a Promise to Patients

PhRMA  |  Blog Post

For more, check out PhRMA CEO John Castellani’s column today in The Morning Consult on the 340B program.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-keeping-a-promise-to-patients

340B Spotlight: Hospital system adds voice to comments about flawed 340B program

PhRMA  |  Blog Post

Learn more at PhRMA.org/340B.
https://catalyst.phrma.orghttps://catalyst.phrma.org/340b-spotlight-hospital-system-adds-voice-to-comments-about-flawed-340b-program

340B Spotlight: Rapid growth of contract pharmacies

PhRMA  |  Blog Post

The location of these contract pharmacies is also a cause for concern.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-spotlight-rapid-growth-of-contract-pharmacies

340B Program in urgent need of expanded Congressional and administrative oversight, reform

PhRMA  |  Press Release

As additional evidence that the program has expanded beyond true safety net hospitals, the analysis revealed that about one-fifth of 340B hospitals provide 80 percent of all charity care delivered by 340B hospitals.
https://www.phrma.org/press-release/340b-program-in-urgent-need-of-expanded-congressional-and-administrative-oversight-reform

340B Spotlight: New analysis finds 340B program growth continues to accelerate despite false claims

PhRMA  |  Blog Post

Read the full BRG report here and learn more about 340B here.
https://catalyst.phrma.org/340b-spotlight-new-analysis-finds-340b-program-growth-continues-to-accelerate-despite-false-claims

340B Spotlight: ICYMI – AJC looks at how some Georgia hospitals are profiting off 340B

PhRMA  |  Blog Post

Learn more at PhRMA.org/340B.
https://catalyst.phrma.org/340b-spotlight-icymi-ajc-looks-at-how-some-georgia-hospitals-are-profiting-off-340b

340B Drug Purchases and Population without Drug Coverage

PhRMA  |  Graphic

Drug purchases through the 340B program will continue to rise, at the same time the share of the population without prescription drug coverage will nearly drop in half.
https://www.phrma.org/graphic/trends-in-340b-drug-purchases-and-percent-of-total-population-without-prescription-drug-coverage

340B Spotlight: Retail pharmacies continue to expand the 340B program

PhRMA  |  Blog Post

Currently, there are no rules regarding how covered entities use revenue from the 340B program, and there is no obligation that patients who cannot afford their medicines receive the 340B discount when they try to fill a prescription at a contract pharmacy.
https://catalyst.phrma.orghttp://catalyst.phrma.org/retail-pharmacies-continue-to-expand-the-340b-program

340B Spotlight: A Look at 340B Purchases

PhRMA  |  Blog Post

By 2019, the Berkeley Research Group projects the 340B program will account for 8.0 percent of sales.
https://catalyst.phrma.orghttp://catalyst.phrma.org/340b-spotlight-a-look-at-340b-purchases

You have reviewed the first 25 results out of 552. Each page contains 25 results. You're on page 1.

prev 1 2 3 4 5 6 next